Sagent Pharmaceuticals, Nichi-Iko deal

Nichi-Iko will acquire generics company Sagent for $21.75 per share in cash in a deal the companies say

Read the full 188 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE